{"id":77596,"date":"2012-10-29T15:33:00","date_gmt":"2012-10-29T15:33:00","guid":{"rendered":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/"},"modified":"2012-10-29T15:33:00","modified_gmt":"2012-10-29T15:33:00","slug":"nova-guia-de-seguiment-farmacoterapeutic-amb-spd","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/","title":{"rendered":"Nueva gu\u00eda de seguimiento farmacoterap\u00e9utico con SPD"},"content":{"rendered":"<p>\u00a0<\/p>\n<p>\u00a0<strong>Una nueva Gu\u00eda de Seguimiento Farmacoterap\u00e9utico con SPD contribuir\u00e1 a optimizar los resultados de adherencia farmacoterap\u00e9utica de los enfermos cr\u00f3nicos<\/strong><\/p>\n<p align=\"justify\">29\/10\/2012.- La nueva Gu\u00eda de Seguimiento Farmacoterap\u00e9rutico con Sistemas Personalizados de Dosificaci\u00f3n (SPD), elaborada por representantes del Consejo de Colegios Farmac\u00e9uticos de Catalu\u00f1a y del Departamento de Salud de la Generalitat,\u00a0<strong>contribuir\u00e1<\/strong>\u00a0<strong>a mejorar la optimizaci\u00f3n de resultados terap\u00e9uticos a los usuarios del servicio<\/strong>. La Gu\u00eda proporciona las herramientas para que las farmacias re\u00fanan los requisitos para preparar los SPD dentro del servicio de Seguimiento Farmacoterap\u00e9utico, lo que permitir\u00e1 evaluar sus resultados.<\/p>\n<p align=\"justify\"><strong>Garant\u00eda de mejora en la salud del paciente<\/strong><\/p>\n<p align=\"justify\">Despu\u00e9s de m\u00e1s de doce a\u00f1os proporcionando sistemas personalizados de dosificaci\u00f3n a los pacientes para optimizar la adherencia a los tratamientos, se ha dado un paso adelante para integrar esta actividad dentro del servicio de seguimiento farmacoterap\u00e9utico, de acuerdo con el marco legal establecido por la Ley de Garant\u00edas, modificada por Real Decreto Ley 9\/2011.<\/p>\n<p align=\"justify\">As\u00ed, la nueva Gu\u00eda de Seguimiento Farmacoterap\u00e9utico con SPD actualiza el procedimiento de trabajo que ya ten\u00edan establecidos los colegios y enmarca este servicio profesional dentro de la actual normativa. Adem\u00e1s, establece los sistemas personalizados de dosificaci\u00f3n como herramienta de mejora en la adherencia al tratamiento en los pacientes a los que se les est\u00e1 realizando el seguimiento farmacoterap\u00e9utico.<\/p>\n<p align=\"justify\">Esta Gu\u00eda se considera el punto de partida para el registro de las intervenciones de los farmac\u00e9uticos que ya proporcionan el servicio, siendo adem\u00e1s el paso previo a la posible concertaci\u00f3n de este servicio en determinados pacientes. Con esta Gu\u00eda se pretende garantizar un mismo servicio de calidad a todos los usuarios que reciban el seguimiento farmacoterap\u00e9utico con SPD.<\/p>\n<p align=\"justify\">La Gu\u00eda se ha presentado a los farmac\u00e9uticos catalanes y establece un per\u00edodo de adaptaci\u00f3n para aquellos farmac\u00e9uticos que actualmente ya est\u00e1n proporcionando el servicio. Este per\u00edodo de adaptaci\u00f3n incluye la actualizaci\u00f3n de la formaci\u00f3n y el procedimiento de la autorizaci\u00f3n administrativa.<\/p>\n<p align=\"justify\"><strong>Para m\u00e1s informaci\u00f3n<\/strong>:<br \/>Departamento de Comunicaci\u00f3n\u00a0<br \/><a href=\"mailto:premsa@cofb.net\">premsa@cofb.net<\/a>\u00a0<br \/>93 244 07 28\/18<\/p>\n<p>\u00a0\u00a0Una nueva Gu\u00eda de Seguimiento Farmacoterap\u00e9utico con SPD contribuir\u00e1 a optimizar los resultados de adherencia farmacoterap\u00e9utica de los enfermos cr\u00f3nicos29\/10\/2012.- La nueva Gu\u00eda de Seguimiento Farmacoterap\u00e9rutico con Sistemas Personalizados de Dosificaci\u00f3n (SPD), elaborada por representantes del Consejo de Colegio Farmac\u00e9uticos de Catalu\u00f1a y del Departamento de Salud de la Generalitat, contribuir\u00e1 a mejorar la optimizaci\u00f3n de resultados terap\u00e9uticos a los usuarios del servicio. La Gu\u00eda proporciona las herramientas para que las farmacias re\u00fanan los requisitos para preparar los SPD dentro del servicio de Seguimiento Farmacoterap\u00e9utico, lo que permitir\u00e1 evaluar sus resultados. Garant\u00eda de mejora en la salud del paciente Tras m\u00e1s de doce a\u00f1os proporcionando sistemas personalizados de dosificaci\u00f3n a los pacientes para optimizar la adherencia a los tratamientos, se ha dado un paso adelante para integrar esta actividad dentro del servicio de seguimiento farmacoterap\u00e9utico, de acuerdo al marco legal establecido por la Ley de Garant\u00edas, modificada por el Real decreto Ley 9\/2011. la nueva Gu\u00eda de Seguimiento Farmacoterap\u00e9utico con SPD actualiza el procedimiento de trabajo que ya ten\u00edan establecidos los colegios y enmarca este servicio profesional dentro de la actual normativa. Adem\u00e1s, establece los sistemas personalizados de dosificaci\u00f3n como herramienta de mejora en la adherencia al tratamiento en los pacientes a los que se les est\u00e1 realizando el seguimiento farmacoterap\u00e9utico. Esta Gu\u00eda se considera el punto de partida para el registro de las intervenciones de los farmac\u00e9uticos que ya proporcionan el servicio, y adem\u00e1s es el paso previo a la posible concertaci\u00f3n de ese servicio en determinados pacientes. Con esta Gu\u00eda se pretende garantizar un mismo servicio de calidad a todos los usuarios que reciban el seguimiento farmacoterap\u00e9utico con SPD. La Gu\u00eda se ha presentado a los farmac\u00e9uticos catalanes y establece un per\u00edodo de adaptaci\u00f3n para aquellos farmac\u00e9uticos que actualmente ya est\u00e1n proporcionando el servicio. Este per\u00edodo de adaptaci\u00f3n incluye la actualizaci\u00f3n de la formaci\u00f3n y el procedimiento de la autorizaci\u00f3n administrativa.Para m\u00e1s informaci\u00f3n:Departamento de Comunicaci\u00f3n prensa@cofb.net 93 244 07 28\/18<\/p>","protected":false},"excerpt":{"rendered":"<p>\u00a0 \u00a0Una nueva Gu\u00eda de Seguimiento Farmacoterap\u00e9utico con SPD contribuir\u00e1 a optimizar los resultados de adherencia farmacoterap\u00e9utica de los enfermos cr\u00f3nicos 29\/10\/2012.- La nueva Gu\u00eda de Seguimiento Farmacoterap\u00e9rutico con Sistemas Personalizados de Dosificaci\u00f3n (SPD), elaborada por representantes del Consejo de Col\u00b7 legis Farmac\u00e9uticos de Catalu\u00f1a y del Departamento de Salud de la Generalitat, contribuir\u00e1 a [\u2026]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1060,1066],"tags":[],"class_list":["post-77596","post","type-post","status-publish","format-standard","hentry","category-notes-premsa","category-sense-categoria-ca"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nova guia de seguiment farmacoterap\u00e8utic amb SPD - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nova guia de seguiment farmacoterap\u00e8utic amb SPD - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u00a0 \u00a0Una nova Guia de Seguiment Farmacoterap\u00e8utic amb SPD contribuir\u00e0 a optimitzar els resultats d\u2019adher\u00e8ncia farmacoterap\u00e8utica dels malalts cr\u00f2nics 29\/10\/2012.- La nova Guia de Seguiment Farmacoterap\u00e8rutic amb Sistemes Personalitzats de Dosificaci\u00f3 (SPD), elaborada per representants del Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya i del Departament de Salut de la Generalitat,\u00a0contribuir\u00e0\u00a0a [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2012-10-29T15:33:00+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Nova guia de seguiment farmacoterap\u00e8utic amb SPD\",\"datePublished\":\"2012-10-29T15:33:00+00:00\",\"dateModified\":\"2012-10-29T15:33:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/\"},\"wordCount\":705,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"articleSection\":[\"Notes de premsa\",\"Sense categoria\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/\",\"name\":\"Nova guia de seguiment farmacoterap\u00e8utic amb SPD - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"datePublished\":\"2012-10-29T15:33:00+00:00\",\"dateModified\":\"2012-10-29T15:33:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nova guia de seguiment farmacoterap\u00e8utic amb SPD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nova guia de seguiment farmacoterap\u00e8utic amb SPD - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/","og_locale":"es_ES","og_type":"article","og_title":"Nova guia de seguiment farmacoterap\u00e8utic amb SPD - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u00a0 \u00a0Una nova Guia de Seguiment Farmacoterap\u00e8utic amb SPD contribuir\u00e0 a optimitzar els resultats d\u2019adher\u00e8ncia farmacoterap\u00e8utica dels malalts cr\u00f2nics 29\/10\/2012.- La nova Guia de Seguiment Farmacoterap\u00e8rutic amb Sistemes Personalitzats de Dosificaci\u00f3 (SPD), elaborada per representants del Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya i del Departament de Salut de la Generalitat,\u00a0contribuir\u00e0\u00a0a [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2012-10-29T15:33:00+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Nova guia de seguiment farmacoterap\u00e8utic amb SPD","datePublished":"2012-10-29T15:33:00+00:00","dateModified":"2012-10-29T15:33:00+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/"},"wordCount":705,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"articleSection":["Notes de premsa","Sense categoria"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/","url":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/","name":"Nova guia de seguiment farmacoterap\u00e8utic amb SPD - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"datePublished":"2012-10-29T15:33:00+00:00","dateModified":"2012-10-29T15:33:00+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2012\/10\/29\/nova-guia-de-seguiment-farmacoterapeutic-amb-spd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Nova guia de seguiment farmacoterap\u00e8utic amb SPD"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u00a0 \u00a0Una nova Guia de Seguiment Farmacoterap\u00e8utic amb SPD contribuir\u00e0 a optimitzar els resultats d\u2019adher\u00e8ncia farmacoterap\u00e8utica dels malalts cr\u00f2nics 29\/10\/2012.- La nova Guia de Seguiment Farmacoterap\u00e8rutic amb Sistemes Personalitzats de Dosificaci\u00f3 (SPD), elaborada per representants del Consell de Col\u00b7legis Farmac\u00e8utics de Catalunya i del Departament de Salut de la Generalitat,\u00a0contribuir\u00e0\u00a0a [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/77596","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=77596"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/77596\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=77596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=77596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=77596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}